Stevanato Group S.p.a. income statement

In fiscal 2025, Stevanato Group S.p.a. reported revenue of $1.34bn, up 12.3% on the year before, operating income of $225m (a 16.8% margin) and net income of $158m, or $0.58 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Stevanato Group S.p.a.: income statement, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	601	755	998	1,036	1,174	1,195	1,341
Cost of revenue	446	534	684	699	806	867	952
Gross profit	155	222	314	337	368	327	389
Research and development	9	20	35	36	39	34	29
Operating income	70	118	192	203	217	174	225
Interest expense	5	6	5	4	4	7	6
Income before tax	61	110	196	198	205	173	214
Income tax	18	20	37	47	47	46	56
Net income	44	90	159	150	158	127	158
Diluted EPS	$0.18	$0.38	$0.63	$0.57	$0.59	$0.47	$0.58
Diluted shares (average)	241m	241m	253m	265m	265m	271m	273m
EBITDA	121	179	259	271	302	—	—

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: HAE vs STVN PEN vs STVN MMSI vs STVN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Stevanato Group S.p.a.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Stevanato Group S.p.a.